For Immediate Release

Milliman Care Guidelines Customized for UK Market Launch

Seattle – October 31, 2006 – Milliman Care Guidelines has introduced a new version of its evidence-based clinical guidelines, customized to meet the needs of UK healthcare professionals.

“We are extremely pleased to be entering the UK market with tools that have improved clinical outcomes for millions of patients worldwide, ” said James Schibanoff, MD, Editor-in-Chief at Milliman Care Guidelines. “Delivery of quality medical care is a global issue, so customizing the Care Guidelines for the UK is a logical development for us.”

The Milliman Care Guidelines^® are clinical decision support tools used for treating specific patient conditions with appropriate levels of care and optimal progression toward discharge or transition. They are written and reviewed by experienced physicians, nurses, and other clinicians to describe current best medical practice, recognizing that the unique circumstances of the patient should guide medical decisions. These clinical tools provide up-to-date, evidence-based knowledge, enabling more informed, consistent decisions and promoting the best possible care management, while maximizing efficiency in the use of healthcare resources.

The team that develops and reviews the complete Care Guidelines series has more than 50 years of clinical guideline development experience, relying on a rigorous, evidence-based methodology. During the annual guideline development process, Milliman editors review more than 100,000 medical articles worldwide, including 13,000 references deemed significant or relevant enough to be cited in the latest edition. The UK’s NICE (National Institute for Health and Clinical Evidence) Guidelines are included in the UK version. This evidence is integrated throughout the Care Guidelines’ succinct, easy-to-use Web format, using embedded links to provide users with simple access to annotated bibliographies, references and footnotes.

BUPA Health Insurance, which provides cover for more than three million people in the UK is the first UK healthcare company to be licensed to use the guidelines. Dr. Natalie-Jane Macdonald, BUPA Health Insurance’s Medical and Healthcare Purchasing Director said: “We will use the new guidelines to equip our clinical staff with information to ensure that decisions to fund treatment are clinically sound, consistently delivered and sufficiently flexible to recognize variation in individual patient circumstances. This is a further demonstration of our commitment to ensure that our insured members have access to the highest standards of medical care.”

Milliman Care Guidelines

Milliman Care Guidelines LLC, a Milliman Company, is located in Seattle, Washington and has been producing evidence-based clinical guidelines since 1990. The Care Guidelines are used to support the care of one in three Americans. The annually-updated, six-product Care Guidelines series includes Ambulatory Care, Inpatient and Surgical Care, General Recovery Guidelines, Recovery Facility Care, Home Care, and Chronic Care Guidelines. For more information, visit www.careguidelines.com.

Seattle-based Milliman serves the full spectrum of business, financial, government, and union organizations. Founded in 1947 as Milliman & Robertson, the company has 33 offices in the United States as well as offices in Amsterdam, Bermuda, Hong Kong, London, Madrid, Mexico City, Milan, Munich, New Delhi, Sao Paulo, Seoul, Tokyo, Warsaw and Zurich. Milliman employs more than 2,000 people, including a professional staff of over 850 qualified consultants and actuaries. The firm has consulting practices in employee benefits, healthcare, life insurance/financial services, and property & casualty insurance. It is a founding member of Milliman Global, an international organization of consulting firms serving insurance, employee benefits and healthcare clients worldwide. For further information visit www.milliman.com.

BUPA Health Insurance

BUPA was founded in 1947 and today is the UK’s leading health insurer providing cover for over three million people including staff working in more thanhalf the FTSE 100 companies. BUPA is the only health insurer to have established specialist treatment networks for common cancers (breast, bowel and gynaecological), bone marrow stem cell transplants and MRI facilities. Later this year, it hopes to introduce an ophthalmology network. A report by the UK’s leading cancer information charity Cancer BACUP in 2004 highlighted the fact that BUPA is the only insurer to provide cover for patients at every stage of their cancer. BUPA also gives members access to effective medicines and treatments, often before they become widely available eg, Trastuzumab (Herceptin) and Bevacizumab (Avastin) for early stage breast, bowel and lung cancers.

BUPA spends more than £1.5bn on care for its members including £150m on cancer care. It has no shareholders and no dividends to pay.Any profit is reinvested to provide better health and care for customers.

Contact:

Vice President of Sales Milliman Care Guidelines Tel +1 206 381 8160 bill.mckinley@milliman.com

Anne Marie Cooklin BUPA Health Insurance Tel +44 207 656 2084 Cell +1 480 203 7268 cooklina@bupa.com